Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Good Relations to support launch of OTC drugs from infirst Healthcare

Follows five-way competitive pitch

Novartis day

Novartis’ combo COPD inhaler cleared in EU

Becomes first dual action bronchodilator approved in EU for COPD

FDA takes ‘tailored’ approach to mobile app regulation

Issues final guidance on smartphone and tablet computer technology

- PMLiVE

FDA rejects Merck muscle relaxant drug once again

Regulator still has hypersensitivity concerns about Bridion

- PMLiVE

Two new hires for Bamboo

Health communications firm recruits Tim Schofield and Emily Ball to its client services team

- PMLiVE

WCRS creates new Bupa campaign

‘Our focus is your health’ says health insurer in its new-multi media campaign

- PMLiVE

Playing hard to get: What pharma can really learn from the luxury industry

Pharma should look to premium brands for inspiration rather than FMCG

Roche - Basel

Roche’s Kadcyla and Bayer’s Xofigo near EU approval

Cancer drugs receive CHMP backing

- PMLiVE

GSK wins anthrax contract from US government

Signs $196m deal for its monoclonal anti-toxin raxibacumab

- PMLiVE

GSK antisense drug fails muscular dystrophy trial

Company and its partner Prosensa suffer setback with drisapersen

- PMLiVE

EMA backs drugs from Novo, Otsuka, AZ, Janssen, GSK

Nine new branded medicines recommended for use in Europe

What did the iPad ever do for us?

Tablets are here to stay, but capitalising on them requires moments of ‘wow’

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links